Viewing StudyNCT00151073



Ignite Creation Date: 2024-05-05 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00151073
Status: COMPLETED
Last Update Posted: 2015-01-22
First Post: 2005-09-06

Brief Title: Estramustine Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
Sponsor: University of Michigan Rogel Cancer Center
Organization: University of Michigan Rogel Cancer Center

Conditions & Keywords Data

Conditions:
Name
Hormone-Refractory Prostate Cancer
Keywords:
Name View
Metastatic Prostate Cancer View
Zometa View
Prostate Cancer View